Benlysta (Belimumab)

200 mg/mL · Solution

By GlaxoSmithKline LLC

Belimumab · Solution · 200 mg/mL · Subcutaneous

NDC: 49401-0088
Route: Subcutaneous
Therapeutic class: B Lymphocyte Stimulator-directed Antibody Interactions [MoA], B Lymphocyte Stimulator-specific Inhibitor , Decreased B Lymphocyte Activation [PE]
Marketing category: BLA

Request This Medication

*Expect a reply within 2 business hours with availability and pricing.

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request a Quote

Request this medication.

Tell us the quantity you need and we’ll respond with availability, lot details, dating, and pricing within 2 business hours. Mark it as Rush or Emergency if you need it faster.

DSCSA-compliant pedigree on every order
Cold-chain capable where applicable
Same-day fulfillment available for urgent needs